Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

109.30 +1.16 (+1.07%)

Streaming Delayed Price Updated: 9:42 AM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

53 54 Next >

Why Abbott Laboratories Stock Was a Winner on Wednesday ↗

October 16, 2024

Investors bumped its shares higher following a decent, if unspectacular, earnings report.

Via The Motley Fool

Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript ↗

October 16, 2024

ABT earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Tech Stocks Stall, Small Caps Surge As Regional Banks Rally, Airlines Rocket: What's Driving Markets Wednesday? ↗

October 16, 2024

Small-cap stocks outperformed large caps in Wednesday's session, with the Russell 2000 Index surging to test July 2024 highs on the back of expectations for interest rate cuts and a strong rally in...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 16, 2024

Via Benzinga

Price Over Earnings Overview: Abbott Laboratories ↗

October 16, 2024

Via Benzinga

Abbott Labs Earnings Edge Past Q3 Views, Led By Medical Devices ↗

October 16, 2024

Medical devices led organic sales growth.

Via Investor's Business Daily

A Glimpse of Abbott Laboratories's Earnings Potential ↗

October 15, 2024

Via Benzinga

US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results ↗

October 16, 2024

Via Benzinga

Abbott’s Growth and Dividends Make It a Smart Portfolio Pick

October 16, 2024

Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results align with the trend.

Via MarketBeat

Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast ↗

October 16, 2024

Abbott Laboratories reported third-quarter 2024 sales of $10.64B, with Medical Devices leading 11.7% sales growth. Adjusted EPS of $1.21 beat analyst expectations. Full-year guidance was updated.

Via Benzinga

US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips ↗

October 16, 2024

U.S. stock futures point to a flattish start on Wednesday after the S&P 500 Index and the Dow Jones Industrial Average retreated from record highs in the previous session.

Via Benzinga

Topics Stocks

Beyond The Numbers: 9 Analysts Discuss Abbott Laboratories Stock ↗

October 14, 2024

Via Benzinga

A Look Into Abbott Laboratories Inc's Price Over Earnings ↗

October 08, 2024

Via Benzinga

How Is The Market Feeling About Abbott Laboratories? ↗

October 07, 2024

Via Benzinga

Abbott Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

October 16, 2024

Via Benzinga

Nasdaq Dips 1% Amid Plunge In Chipmaker Stocks: Fear & Greed Index Moves To 'Greed' Zone ↗

October 16, 2024

Via Benzinga

Morgan Stanley, Abbott Laboratories And 3 Stocks To Watch Heading Into Wednesday ↗

October 16, 2024

Via Benzinga

Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce ↗

October 14, 2024

Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana.

Via Talk Markets

Columbus Day: Is Stock Market Open Today? ↗

October 14, 2024

Investors should brace for a busy week with earnings reports from major companies.

Via Benzinga

Navigating 6 Analyst Ratings For Abbott Laboratories ↗

September 26, 2024

Via Benzinga

Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth ↗

October 08, 2024

Abbott Laboratories' MedTech portfolio currently contributes around 45% of total sales of about $42 billion.

Via Benzinga

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

October 08, 2024

Via Benzinga

3 Magnificent Dividend Stocks to Buy in October ↗

October 06, 2024

These dividend stocks are great picks as the fall season gets underway.

Via The Motley Fool

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades ↗

October 05, 2024

Investors can find market-trouncing blue chip stocks in the healthcare industry.

Via The Motley Fool

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. ↗

October 03, 2024

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Via Investor's Business Daily

Topics Stocks

Down More Than 50%, Is DexCom Stock a Bargain Now? ↗

October 02, 2024

Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.

Via The Motley Fool

2 Excellent Dividend Stocks to Buy With Less Than $200 ↗

September 28, 2024

Abbott Laboratories and Johnson & Johnson both have raised their dividends annually for more than 50 years.

Via The Motley Fool

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

September 25, 2024

These dividend players could lift your portfolio no matter what the market is doing.

Via The Motley Fool

Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst ↗

September 19, 2024

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation.

Via Benzinga

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

September 19, 2024

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.